Kinase-dependent regulation of the secretion of thyrotrophin and luteinizing hormone by glucocorticoids and annexin 1 peptides

Journal of Neuroendocrinology

Volumn 15, Issue 10, 2003, Pages 946-957

  John, C D ^a   Christian, H C ^b   Morris, J F ^b   Flower, R J ^c   Solito, E ^a   Buckingham, Julia C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Annexin 1; Glucocorticoids; Luteinizing hormone; Protein kinase C; Thyrotrophin; Tyrosine kinase

Indexed keywords

DEXAMETHASONE; FORSKOLIN; GENISTEIN; GLUCOCORTICOID; LIPOCORTIN 1; LIPOCORTIN 5; LUTEINIZING HORMONE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; STEROID; THYROTROPIN; TYROSINE;

ADENOHYPOPHYSIS; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME SUBSTRATE; HYPOPHYSIS CELL; IN VITRO STUDY; LUTEINIZING HORMONE RELEASE; MALE; MEMBRANE TRANSPORT; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; THYROTROPIN RELEASE;

AMINO ACID SEQUENCE; ANIMALS; ANNEXIN A1; ANNEXIN A5; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FORSKOLIN; GLUCOCORTICOIDS; LUTEINIZING HORMONE; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PITUITARY GLAND; PITUITARY GLAND, ANTERIOR; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; THYROTROPIN;

EID: 0141669348     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2003.01081.x     Document Type: Article

References (69)

1. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53: 865-871.
2. Marazuela M, Cuerda C, Lucas T, Vicente A, Blanco C, Estrada J. Anterior pituitary function after adrenalectomy in patients with Cushing's syndrome. Postgrad Med J 1993; 69: 547-551.
3. Hangaard J, Andersen M, Grodum E, Koldkjaer O, Hagen C. Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy. J Clin Endocrinol Metab 1996; 81: 2502-2507.
4. Magiakou MA, Chrousos GP. Corticosteroid therapy, nonendocrine disease, and corticosteroid withdrawal. Curr Ther Endocrinol Metab 1997; 6: 138-142.
5. Cintra A, Fuxe K, Wikstrom AC, Visser T, Gustafsson JA. Evidence for thyrotropin-releasing hormone and glucocorticoid receptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat. Brain Res 1990; 506: 139-144.
6. Kakueska I, Qi Y, Lechan RM. Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone. Endocrinology 1995; 136: 2795-2802.
7. Briski KP, Vogel KL. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat. Neuropeptides 1995; 28: 175-181.
8. Tilbrook AJ, Turner AI, Clarke IJ. Effects of stress on reproduction in non-rodent mammals: the role of glucocorticoids and sex differences. Rev Reprod 2000; 5: 105-113.
9. Taylor AD, Flower RJ, Buckingham JC. Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1. J Endocrinol 1995; 147: 533-544.
10. Taylor AD, Cowell AM, Flower J, Buckingham JC. Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology 1993; 58: 430-439.
11. Taylor AD, Philip JG, John CD, Cover PO, Morris JF, Flower RJ, Buckingham JC. Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3′,5′-monophosphate-stimulated prolactin secretion. Endocrinology 2000; 141: 2209-2219.
12. Buckingham JC, Flower RJ. Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis. Mol Med Today 1997; 3: 296-302.
13. Goulding NJ, Guyre PM. Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 1993; 5: 108-113.
14. Smith T, Flower RJ, Buckingham JC. Lipocortins 1, 2 and 5 in the central nervous system and pituitary gland of the rat: selective induction by dexamethasone of lipocortin 1 in the anterior pituitary gland. Mol Neuropharmacol 1993; 3: 45-55.
15. Traverso V, Christian HC, Morris JF, Buckingham JC. Lipocortin 1 (annexin 1): a candidate paracrine agent localized in pituitary folliculo-stellate cells. Endocrinology 1999; 140: 4311-4319.
16. Chapman L, Nishimura A, Buckingham JC, Morris JF, Christian HC. Externalization of annexin I from a folliculo-stellate-like cell line. Endocrinology 2002; 143: 4330-4338.
17. Philip JG, Flower RJ, Buckingham JC. Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro. Neuroreport 1997; 8: 1871-1876.
18. Buckingham JC. Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis. the pivotal role of glucocorticoids and lipocortin 1. Br J Pharmacol 1996; 118: 1-19.
19. Morris JF, Christian HC, Chapman LP, Epton MJ, Buckingham JC, Ozawa H, Nishi M, Kawata M. Steroid effects on secretion from subsets of lactotrophs: role of folliculo-stellate cells and annexin 1. Arch Physiol Biochem 2002; 110: 54-61.
20. Christian HC, Taylor AD, Flower RJ, Morris JF, Buckingham JC. Characterization and localization of lipocortin 1-binding sites on rat anterior pituitary cells by fluorescence-activated cell analysis/sorting and electron microscopy. Endocrinology 1997; 138: 5341-5351.
21. Taylor AD, Christian HC, Morris JF, Flower RJ, Buckingham JC. An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. Endocrinology 1997; 138: 2909-2918.
22. Taylor AD, Cowell AM, Flower RJ, Buckingham JC. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms. Neuroendocrinology 1995; 62: 530-542.
23. Browning JL, Ward MP, Wallner BP, Pepinsky RB. Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids. Prog Clin Biol Res 1990; 349: 27-45.
24. Cirino G, Cicala C, Sorrentino L, Ciliberto G, Arpaia G, Perretti M, Flower RJ. Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1. Br J Pharmacol 1993; 108: 573-574.
25. Croxtall JD, Waheed S, Choudhury Q, Anand R, Flower RJ. N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int J Cancer 1993; 54: 153-158.
26. Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol 1993; 151: 4306-4314.
27. Croxtall JD, Choudhury Q, Flower RJ. Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: identification of E-Q-E-Y-V as a crucial component. Br J Pharmacol 1998; 123: 975-983.
28. John C, Cover P, Solito E, Morris J, Christian H, Flower R, Buckingham J. Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. Endocrinology 2002; 143: 3060-3070.
29. Haigler HT, Schlaepfer DD, Burgess WH. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors. J Biol Chem 1987; 262: 6921-6930.
30. Schlaepfer DD, Haigler HT. In vitro protein kinase C phosphorylation sites of placental lipocortin. Biochemistry 1988; 27: 4253-4258.
31. Glenney JR Jr, Tack BF. Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. Proc Natl Acad Sci USA 1985; 82: 7884-7888.
32. De BK, Misono KS, Lukas TJ, Mroczkowski B, Cohen S. A calcium dependent 35 KDa substrate for EGF receptor kinase isolated from normal tissue. J Biol Chem 1986; 261: 13784-13792.
33. Rothhut B. Participation of annexins in protein phosphorylation. Cell Mol Life Sci 1997; 53: 522-526.
34. Solito E, Mulla A, Morris JF, Christian HC, Flower RJ, Buckingham JC. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 2003; 144: 1164-1174.
35. de Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 2000; 31: 371-380.
36. 2+-dependent phospholipid binding and phosphorylation of lipocortin I. J Biol Chem 1987; 262: 6931-6937.
37. Buckingham JC, Hodges JR. The use of corticotrophin production by adenohypophysial tissue in vitro for the detection and estimation of potential corticotrophin releasing factors. J Endocrinol 1977; 72: 187-193.
38. Taylor AD, Christian HC, Morris JF, Flower RJ, Buckingham JC. Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1). Br J Pharmacol 2000; 131: 1309-1316.
39. Reichlin S, Martin JB, Boshans RL, Schalch DS, Pierce JG, Bollinger J. Measurement of TSH in plasma and pituitary of the rat by a radio-immunoassay utilizing bovine TSH: effect of thyroidectomy or thyroxine administration on plasma TSH levels. Endocrinology 1970; 87: 1022-1031.
40. Kilpatrick MJ, Collins WP, Newton JR. Studies on the release of gonadotrophins during the superfusion of isolated rat pituitaries in a continuous flow system. J Reprod Fertil 1976; 46: 25-30.
41. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
42. Perretti M, Flower RJ. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993; 150: 992-999.
43. Croxtall JD, Flower RJ. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci USA 1992; 89: 3571-3575.
44. Hoekstra D, Buist-Arkema R, Klappe K, Reutelingsperger CP. Interaction of annexins with membranes: the N-terminus as a governing parameter as revealed with a chimeric annexin. Biochemistry 1993; 32: 14194-14202.
45. Lim LH, Solito E, Russo-Marie F, Flower RJ, Perretti M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci USA 1998; 95: 14535-14539.
46. Loxley HD, Cowell AM, Flower RJ, Buckingham JC. Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release? Neuroendocrinology 1993; 57: 801-814.
47. House C, Kemp BE. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 1987; 238: 1726-1728.
48. Sato K, Miki S, Tachibana H, Hayashi F, Akiyama T, Fukami Y. A synthetic peptide corresponding to residues 137-157 of p60v-src inhibits tyrosine-specific protein kinases. Biochem Biophys Res Commun 1990; 171: 1152-1159.
49. Ahlgren SC, Levine JD. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol 1994; 72: 684-692.
50. Gonzalez A, Klann E, Sessoms JS, Chen SJ. Use of the synthetic peptide neurogranin (28-43) as a selective protein kinase C substrate in assays of tissue homogenates. Anal Biochem 1993; 215: 184-189.
51. 2+ action potential frequency by a small G protein Rab3A in rat pituitary GH3 cells. Biochem Biophys Res Commun 1997; 235: 331-335.
52. Ogawara H, Akiyama T, Ishida J, Watanabe S, Suzuki K. A specific inhibitor for tyrosine protein kinase from Pseudomonas. J Antibiot (Tokyo) 1986; 39: 606-608.
53. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592-5595.
54. 2+ entry in human platelets. FEBS Lett 1993; 315: 242-246.
55. 2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J 1990; 266: 195-200.
56. Raynal P, Hullin F, Ragab-Thomas JM, Fauvel J, Chap H. Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells. Biochem J 1993; 292: 759-765.
57. Philip JG, John CD, Cover PO, Morris JF, Christian HC, Flower RJ, Buckingham JC. Opposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1. Br J Pharmacol 2001; 134: 887-895.
58. Ernst JD, Hoye E, Blackwood RA, Mok TL. Identification of a domain that mediates vesicle aggregation reveals functional diversity of annexin repeats. J Biol Chem 1991; 266: 6670-6673.
59. Andree HA, Willems GM, Hauptmann R, Maurer-Fogy I, Stuart MC, Hermens WT, Frederik PM, Reutelingsperger CP. Aggregation of phospholipid vesicles by a chimeric protein with the N-terminus of annexin I and the core of annexin V. Biochemistry 1993; 32: 4634-4640.
60. Bitto E, Cho W. Structural determinant of the vesicle aggregation activity of annexin I. Biochemistry 1999; 38: 14094-14100.
61. Shipston MJ, Armstrong DL. Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumour cells. J Physiol 1996; 493: 665-672.
62. Ozawa H, Miyachi M, Ochiai I, Tsuchiya S, Morris JF, Kawata M. Annexin-1 (lipocortin-1)-immunoreactivity in the folliculo-stellate cells of rat anterior pituitary: the effect of adrenalectomy and corticosterone treatment on its subcellular distribution. J Neuroendocrinol 2002; 14: 621-628.
63. Ozawa H, Ito T, Ochiai I, Kawata M. Cellular localization and distribution of glucocorticoid receptor immunoreactivity and the expression of glucocorticoid receptor messenger RNA in rat pituitary gland. A combined double immunohistochemistry study and in situ hybridization histochemical analysis. Cell Tissue Res 1999; 295: 207-214.
64. Croxtall JD, Choudhury Q, Flower RJ. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 2000; 130: 289-298.
65. Croxtall JD, Choudhury Q, Newman S, Flower RJ. Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation. Biochem Pharmacol 1996; 52: 351-356.
66. Cowell AM, Buckingham JC. Eicosanoids and the hypothalamo-pituitary axis. Prostaglandins Leukot Essent Fatty Acids 1989; 36: 235-250.
67. (2+)-dependent membrane fusion. J Clin Invest 1992; 90: 537-544.
68. Meers P, Mealy T, Pavlotsky N, Tauber AI. Annexin I-mediated vesicular aggregation: mechanism and role in human neutrophils. Biochemistry 1992; 31: 6372-6382.
69. Wang W, Creutz CE. Regulation of the chromaffin granule aggregating activity of annexin I by phosphorylation. Biochemistry 1992; 31: 9934-9939.